02/11/2026
If you’re a US-based SCD family who has undergone gene therapy or hematopoietic stem cell
transplantation (HSCT), you can take part in a study to better understand the overall
experiences of patients and families. Complete the 30-minute survey and a 60-minute follow-up
interview to receive a $200 honorarium.
You’ll be part of a first-of-its-kind study to gain a better understanding of the physical, social,
emotional, and other experiences of Sickle Cell Disease (SCD) Warriors, who have undergone
gene therapy or hematopoietic stem cell transplant (HSCT), and their family members. The
results of this IRB-Approved research will be used to create educational and support resources.
To find out if you’re eligible and share your voice, visit this link, and click the orange “start”
button to begin.
The study is being sponsored and led by Beam Therapeutics, with support from Engage Health.
Note: SCD Warriors who have received gene therapy through the Beam Therapeutics& #39; trial
Beam-101 are not eligible for this study.
https://www.engagehealth.com/survey/LoginCode.aspx?SurveyID=q7KK49m1